Abstract

Gammaherpesviruses are an important class of oncogenic pathogens that are exquisitely evolved to their respective hosts. As such, the human gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi sarcoma herpesvirus (KSHV) do not naturally infect nonhuman primates or rodents. There is a clear need to fully explore mechanisms of gammaherpesvirus pathogenesis, host control, and immune evasion in the host. A gammaherpesvirus pathogen isolated from murid rodents was first reported in 1980; 40 years later, murine gammaherpesvirus 68 (MHV68, MuHV-4, γHV68) infection of laboratory mice is a well-established pathogenesis system recognized for its utility in applying state-of-the-art approaches to investigate virus-host interactions ranging from the whole host to the individual cell. Here, we highlight recent advancements in our understanding of the processes by which MHV68 colonizes the host and drives disease. Lessons that inform KSHV and EBV pathogenesis and provide future avenues for novel interventions against infection and virus-associated cancers are emphasized.

Highlights

  • Murine gammaherpesvirus 68 (MHV68, MuHV-4, γHV68), a natural pathogen of murid rodents, is widely used to discover and understand key pathogenic determinants of in vivo gammaherpesvirus infections

  • MHV68 was isolated from bank voles; related strains have been isolated from bank voles and yellow-necked mice, and numerous rodent species appear to serve as reservoirs

  • Type I IFN cytokines dampen both acute replication and reactivation from latency; their potency is evident in the mortality that manifests in MHV68-infected mice lacking IFNαβ receptor or STAT1 [85]

Read more

Summary

INTRODUCTION

Murine gammaherpesvirus 68 (MHV68, MuHV-4, γHV68), a natural pathogen of murid rodents, is widely used to discover and understand key pathogenic determinants of in vivo gammaherpesvirus infections. MHV68 shares key biologic properties with the human gammaherpesviruses KSHV and Epstein-Barr virus (EBV, HHV-4), including establishment of latency in B cells and propensity to drive tumorigenesis. MHV68 protein products and noncoding RNAs (ncRNAs) engage and usurp germinal center (GC) reactions to gain access to the long-lived memory B cell compartment. Murine gammaherpesvirus 68 (MHV68) encodes a wide breadth of noncoding RNAs (ncRNAs), ranging from 10-kb long ncRNAs (lncRNAs) to 21-nt microRNAs (miRNAs) (Figure 2). As evidenced by the conserved activity of MHV68 transfer RNA-miRNA-encoded RNA (TMER) 4 and Epstein-Barr virus (EBV) encoded small RNA (EBER) 1, many of these molecules likely exhibit functional overlap with EBV and Kaposi sarcoma herpesvirus (KSHV) ncRNAs. Consistent with this, of 1,505 identified host messenger RNA targets of MHV68 miRNAs, 86% are shared with EBV and/or KSHV [142]. Future research will undoubtedly continue to unveil surprising functions for ncRNAs in gammaherpesvirus pathobiology

69 M10 vGPCR 68 vBcl2
PHASES OF THE MHV68 LIFE CYCLE IN VIVO
Acute Phase of Infection
Trafficking to Draining Lymph Nodes and Peripheral Dissemination
Latency and Reactivation
IMMUNE CONTROL OF MHV68 INFECTION
Innate Immune Control
Cell-Mediated Immune Control
Vaccines to Control Gammaherpesvirus Infection and Disease
Oncogenesis Models
Other Disease Models
Coinfection Models
CONCLUDING REMARKS
Findings
SUMMARY POINTS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call